nomifensine has been researched along with Obesity in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbarino, A | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| D'Amico, C | 1 |
| Sambo, P | 1 |
| Passeri, M | 1 |
| Anile, C | 1 |
| Maira, G | 1 |
1 other study available for nomifensine and Obesity
| Article | Year |
|---|---|
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure.
Topics: Adult; Empty Sella Syndrome; Female; Humans; Intracranial Pressure; Metoclopramide; Nomifensine; Obe | 1987 |